Home/SEC 13D/G/LXEOSEC 13D/GLXEO - Lexeo Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks Simplified$LXEO$4.96βΌ -48.44% YTDHealthcareAug 14, 2026 Β· ThinkSabio BlogSEC Filing Update: #LXEO Lexeo Therapeutics, Inc. : $4.96 Sector: Healthcare | YTD: π½ -48.44% The SEC disclosed Today (14-AUG-2026) that BALYASNY ASSET MANAGEMENT LLC has INCREASED #LXEO Shares by 9.31% π’ * Previous Holdings: 7.18M Shares * Current Holdings: 7.84M Shares * Increase+668.17K * Increased(%)+9.31% * Ownership: 9.99% * Estimated Investment Value: $3.12M https://www.thinksabio.com/reports/isr/LXEO Institutional ownership in #LXEO has been steadily rising over the past 5 quarters in Shares: Q1 2025: 28.01M Q2 2025: 42.27M Q3 2025: 49.36M Q4 2025: 76.46M Q1 2026: 79.89M π Institutional activity in the last 30 days for #LXEO: β’ STATE STREET CORP β Increased holdings by 786,533 shares (07-AUG-2026) β’ AFFINITY ASSET ADVISORS, LLC β Increased holdings by 867,302 shares (13-AUG-2026) Share this postπCopy LinkMore filings for $LXEOLXEO - Lexeo Therapeutics, Inc. - SEC Filing Update (13-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 13, 2026LXEO - Lexeo Therapeutics, Inc. - SEC Filing Update (07-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 7, 2026π¬ Comments Loading commentsβ¦Leave a commentPost Commentβ All PostsMore SEC 13D/G